{
    "clinical_study": {
        "@rank": "40216", 
        "acronym": "BIRP", 
        "arm_group": [
            {
                "arm_group_label": "RP patients", 
                "description": "Retinitis Pigmentosa patients"
            }, 
            {
                "arm_group_label": "Controls", 
                "description": "Patients who will be undergoing surgery for macular hole, epiretinal membrane, or vitreomacular traction, patients who have a retinal detachment , patients with neovascular age related macular degeneration and patients with diabetic retinopathy."
            }
        ], 
        "biospec_descr": {
            "textblock": "Anterior Chamber fluid from the eye"
        }, 
        "biospec_retention": "Samples Without DNA", 
        "brief_summary": {
            "textblock": "In this study,  markers of oxidative stress will be measured in the aqueous humour and\n      plasma of RP patients compared to controls."
        }, 
        "brief_title": "Biomarkers In Retinitis Pigmentosa (BIRP)", 
        "condition": "Retinitis Pigmentosa Patients", 
        "condition_browse": {
            "mesh_term": [
                "Retinitis", 
                "Retinitis Pigmentosa"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Signed informed consent and authorization of use and disclosure of protected health\n             information\n\n          -  Age more than or equal to 18 years\n\n          -  For the study group, patients diagnosed with Retinitis Pigmentosa by the\n             investigators\n\n          -  For the control group, patients undergoing vitreoretinal surgery for macular hole,\n             epiretinal membrane, vitreomacular traction, retinal detachment, neovascular AMD and\n             Diabetic Retinopathy will be eligible\n\n        Exclusion Criteria:\n\n          -  \u2022 Patients with active or suspected ocular or periocular infection"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Retinitis Pigmentosa patients and Controls"
            }
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 20, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01949623", 
            "org_study_id": "BIRP"
        }, 
        "intervention": {
            "arm_group_label": [
                "RP patients", 
                "Controls"
            ], 
            "intervention_name": "AC tap", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "May 12, 2014", 
        "location": {
            "contact": {
                "last_name": "Gulnar Hafiz, MD MPH"
            }, 
            "facility": {
                "address": {
                    "city": "Baltimore", 
                    "country": "United States", 
                    "state": "Maryland", 
                    "zip": "21287"
                }, 
                "name": "Wilmer Eye Institute"
            }, 
            "investigator": {
                "last_name": "Peter Campochiaro, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "2", 
        "official_title": "Biomarkers In Retinitis Pigmentosa (BIRP)", 
        "overall_contact": {
            "email": "ghafiz1@jhmi.edu", 
            "last_name": "Gulnar Hafiz, MD, MPH"
        }, 
        "overall_official": {
            "affiliation": "Johns Hopkins University", 
            "last_name": "Peter Campochiaro, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "September 2020", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Aqueous levels of markers of oxidative stress in patients with RP and controls.", 
            "safety_issue": "No", 
            "time_frame": "2 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01949623"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Johns Hopkins University", 
            "investigator_full_name": "Peter A Campochiaro, MD", 
            "investigator_title": "Professor of Ophthalmology and Neuroscience", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Johns Hopkins University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Johns Hopkins University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2013", 
        "study_design": "Observational Model: Case Control, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "May 2014"
    }
}